日本肠外致病性大肠埃希菌种群结构及其与抗菌药物耐药性的关系
研究发现103种CH型,其中CH40-30(占25%)和另外10种CH型(合计35%)构成主要种群;CH40-30对应全球大流行ST131克隆的C/H30分支,与四重QRDR突变(100%)和bla CTX-M(60%)相关,是耐药种群中的优势克隆。
要点
- 日本ExPEC种群中11种主要克隆占比超过一半,CH40-30-ST131-C/H30为优势耐药克隆。
- CH40-30在环丙沙星不敏感、产ESBL及MDR菌株中分别占39%-75%、70%和59%。
- 16%菌株对萘啶酸不敏感且低水平耐药环丙沙星,携带1-2个QRDR突变,分布于多个CH型。
核心结论
- 日本ExPEC种群中11种主要克隆占比超过一半,其中CH40-30-ST131-C/H30是最主要的耐药种群。
研究设计与样本
- 采用fumC和fimH测序(CH分型)定义克隆群,进行18种抗菌药物敏感性试验,检测QRDR突变和β-内酰胺酶。
主要发现
- 共发现103种CH型,CH40-30占25%,另10种CH型合计占35%。
- 环丙沙星不敏感、产ESBL和MDR表型分别占34%、22%和33%。
- CH40-30与四重QRDR突变(100%)和bla CTX-M(60%)相关,在15种抗菌药物不敏感种群中占比39%-75%(环丙沙星最高),在产ESBL菌株中占70%,在MDR菌株中占59%。
- 对萘啶酸不敏感且低水平耐药环丙沙星、携带1或2个QRDR突变的菌株占16%,分布于8种主要和非主要CH型。
临床怎么用
- CH40-30-ST131-C/H30克隆是日本ExPEC耐药优势克隆,临床应关注其所致感染的治疗。
- 低水平环丙沙星耐药且携带1-2个QRDR突变的克隆分布广泛,可能促进非ST131氟喹诺酮耐药克隆的流行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To define the population structure of extraintestinal pathogenic Escherichia coli (ExPEC) in Japan and its relationship with antimicrobial resistance and the major resistance mechanisms for fluoroquinolones and β-lactams, we designed a multicentre prospective study. METHODS: A total of 329 ExPEC isolates were collected at 10 Japanese acute-care hospitals during December 2014. We defined the clonal groups of ExPEC by fumC and fimH sequencing (CH typing). Antimicrobial susceptibility testing of 18 agents and the detection of mutations in quinolone resistance-determining regions (QRDRs) and β-lactamases were performed. RESULTS: Among the study isolates, 103 CH types were found, and CH40-30 (25%) and another 10 CH types (35% in total) constituted the major ExPEC population. Ciprofloxacin non-susceptibility, ESBLs and MDR phenotypes were found in 34%, 22% and 33%, respectively. CH40-30, corresponding to the C/H30 clade of the global pandemic ST131 clone, was associated with four QRDR mutations (100%) and bla CTX-M (60%) and was the most frequent type in 15 antimicrobial-non-susceptible populations (dominating 39%-75% of each population, the highest prevalence for ciprofloxacin), the ESBL producers (70%) and the MDR isolates (59%). Isolates that were non-susceptible to nalidixic acid and low-level resistant to ciprofloxacin with one or two QRDR mutations represented 16% of the study isolates and were distributed among the eight major and non-major CH types. CONCLUSIONS: More than half of the ExPEC population in Japan consisted of 11 major clones. Of these clones, the CH40-30-ST131-C/H30 clone was the predominant antimicrobial-resistant population. The presence of major clones with low-level ciprofloxacin resistance supports the potential future success of a non-ST131 fluoroquinolone-resistant clone.
引用
- Matsumura Y, Noguchi T, Tanaka M, et al. Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance. J Antimicrob Chemother. 2017. PMID: 28077674. doi:10.1093/jac/dkw530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。